Diploma PLC (LON:DPLM) Stock Has Consensus Target Price of GBX 7,400

Diploma PLC (LON:DPLM) has received an average rating of “Moderate Buy” from the eight analysts that are currently covering the firm, MarketBeat.com reports. Two investment analysts have rated the stock with a hold rating and six have issued a buy rating on the company. The average 12 month price objective among analysts that have issued ratings on the stock in the last year is GBX 7,400.

A number of analysts have recently weighed in on DPLM shares. JPMorgan Chase & Co. upped their target price on shares of Diploma from GBX 5,760 to GBX 8,250 and gave the stock an “overweight” rating in a research report on Monday, August 24th. Royal Bank Of Canada reiterated an “outperform” rating and issued a GBX 7,400 price target on shares of Diploma in a research note on Tuesday, September 8th. Finally, Berenberg Bank reissued a “buy” rating and set a GBX 9,000 price target on shares of Diploma in a research report on Monday, July 20th.

Insiders Place Their Bets

In other Diploma news, insider Katie Bickerstaffe  bought 246 shares of the firm’s stock in a transaction on Wednesday, September 23rd. The stock was acquired at an average price of GBX 7,696 per share, with a total value of £18,932.16. Company insiders own 1.14% of the company’s stock.

Diploma Stock Performance

Shares of Diploma stock opened at GBX 7,355 on Friday. The company has a current ratio of 2.06, a quick ratio of 0.80 and a debt-to-equity ratio of 47.65. The firm has a market capitalization of £9.86 billion, a P/E ratio of 52.24, a P/E/G ratio of 2.82 and a beta of 0.92. The business has a fifty day simple moving average of GBX 7,423.55 and a two-hundred day simple moving average of GBX 6,784.07. Diploma has a 12 month low of GBX 4,970 and a 12 month high of GBX 7,980.

About Diploma

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.